Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 EUR | -0.73% | -5.54% | +13.75% |
Apr. 05 | Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors | CI |
Mar. 22 | Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition | MT |
Sales 2023 | 3.91M 4.16M | Sales 2024 * | 5.9M 6.28M | Capitalization | 55.52M 59.14M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.2M | Net income 2024 * | -3M -3.2M | EV / Sales 2023 | 14.2 x |
Net cash position 2023 * | 5.8M 6.18M | Net cash position 2024 * | 1.6M 1.7M | EV / Sales 2024 * | 9.14 x |
P/E ratio 2023 |
-14.4
x | P/E ratio 2024 * |
-18.2
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 65.43% |
1 day | -0.73% | ||
1 week | -5.54% | ||
Current month | +1.11% | ||
1 month | +9.20% | ||
3 months | +16.17% | ||
6 months | +11.43% | ||
Current year | +13.75% |
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehtonen
CEO | Chief Executive Officer | 49 | 19-02-28 |
Director of Finance/CFO | 57 | 21-01-31 | |
Chairman | 53 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 53 | 16-04-30 | |
Director/Board Member | 50 | 19-12-31 | |
Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2.73 | -0.73% | 15,617 |
24-04-18 | 2.75 | -1.79% | 25,848 |
24-04-17 | 2.8 | +1.45% | 13,862 |
24-04-16 | 2.76 | -3.50% | 155,952 |
24-04-15 | 2.86 | -1.04% | 181,723 |
Delayed Quote Nasdaq Helsinki, April 19, 2024 at 11:09 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.75% | 59.22M | |
+72.65% | 12.34B | |
-19.41% | 7.85B | |
+14.98% | 7.13B | |
-5.13% | 5.31B | |
+5.78% | 5B | |
+17.02% | 4.18B | |
-25.36% | 3.76B | |
-40.56% | 2.24B | |
-3.47% | 1.93B |
- Stock Market
- Equities
- BRETEC Stock